Table 2 Influencing factors of SAE
Non-SAE group(CD1-3) (n = 123) | SAE group (CD4-5) (n = 13) | p | |
|---|---|---|---|
Tumor, n (%) | 0.002* | ||
None | 99 (80.5) | 5 (38.5) | |
Yes | 24 (19.5) | 8 (61.5) | |
Remission, n (%) | < 0.001* | ||
None | 17 (13.8) | 8 (61.5) | |
Yes | 106 (86.2) | 5 (38.5) | |
Na+ level, n (%) | 0.075* | ||
Normol (135–148) | 86 (75.4) | 5(38.5) | |
Low(< 135) | 26 (22.8) | 4( 40.0) | |
High(> 148) | 2 (1.8) | 1 (10.0) | |
CD, n (%) | < 0.001* | ||
1 | 107 (87.0) | 0 (0.0) | |
2 | 16 (13.0) | 0 (0.0) | |
3 | 0 (0.0) | 2 (15.4) | |
4 | 0 (0.0) | 11 (84.6) | |
5 | 0 (0.0) | 0 (0.0) | |
BMI, (kg/m2) | 20.43 (± 1.80) | 19.36 (± 2.25) | 0.048 |
adRBC, (1012/L) | 4.02 (± 0.96) | 3.42 (± 0.72) | 0.032 |
adHB, (g/L) | 120.99 (± 22.34) | 98.23 (16.87) | 0.001 |
adAPTT, (s) | 36.86 (± 6.46) | 41.65 (± 5.17) | 0.015 |
WBC, (109/L) | 7.95 (± 4.21) | 12.29 (± 8.75) | 0.002 |
Ne, (109/L) | 6.17 (± 4.09) | 10.83 (± 8.71) | 0.080* |
RBC, (1012/L) | 3.81 (± 0.83) | 3.31 (± 0.71) | 0.039 |
HB, (g/L) | 115.06 (± 18.58) | 96.77 (± 19.53) | 0.001 |